Hereditary Testing Market size is expected to reach USD 13.6 billion by 2030

 Hereditary Testing Industry Overview

The global hereditary testing market size was valued at USD 6.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2022 to 2030.

 

The expanding reproductive genetic health space is one of the key market drivers. Key players such as Natera have reported a continuous increase in test volumes in women’s health genetic testing for inherited conditions. This reflects the growing acceptance of hereditary tests among the population, thereby accelerating revenue growth. COVID-19 had a detrimental impact on the market. For example, after the World Health Organization declared COVID-19 a pandemic, governments all around the world used lockdowns to compel social separation as a prophylactic measure. In every industry, this resulted in upheaval, constraints, challenges, and adjustments.

 

Gather more insights about the market drivers, restrains and growth of the Global Hereditary Testing Market

 

Similarly, the outbreak negatively impacted the inherited genetic analysis sector. This is due to the incapacity of genetic counselors to see clients in person, the failure of doctors to provide guidance, and the laboratory's inability to do the tests. Furthermore, because regulatory bodies such as the Centers for Medicaid Services (CMS) did not recognize genetic counselors as healthcare practitioners, they were prohibited from working during government shutdowns. Clinics also limited face-to-face diagnostic tests to help prevent the disease from spreading. Nonetheless, genetic testing behemoths such as GeneDx provided clinician-ordered genetic screening as a service. Clinics and healthcare practitioners as well as people used telemedicine to provide genetic counseling.

 

Furthermore, a consistent rise in demand for newborn screening has led to an increase in sales of DNA testing kits. Increasing penetration of newborn screening across the globe is further aiding in revenue growth. Reforms in genetic testing guidelines have led to the inclusion of multigene panel testing for hereditary cancer into clinical practice. The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast, ovarian, and colorectal cancers offer information on some of the cancer risk factors and management.

 

The need for genetic testing has increased, resulting in an increase in DNA screening kit purchases. The Virginia Department of General Services Division of Integrated Laboratory Facilities, for example, screened 7,867 newborns for over 31 genetic and metabolic illnesses in November 2019. Increased adoption of newborn screening throughout the world is also contributing to market expansion. The application of multigene panel screening in clinics for hereditary disorders has increased, which is due to the changes in the genetic testing procedures.

 

The National Comprehensive Cancer Network offers information on numerous cancer risk factors as well as treatment guidelines for single and multiple genetic panels. Gradual improvements in distribution strategy are expected to benefit the inherited genetic testing business. By improving distribution services and expanding technical efficiency, technological providers are helping to expand the market. To make bioinformatics technologies available to other universities, companies are using a cloud-based distribution model. Around 14 licensees began actively marketing Non-invasive Prenatal Testing devices utilizing constellation software.

 

Although these hereditary tests have significant advantages over conventional tests, several industry experts cited the cost and security concerns faced by consumers pertaining to the test. Moreover, the lack of effective regulation of the tests is another key area that demands focused efforts. Despite these challenges, the genetic testing market is constantly expanding owing to the advantages of these innovative tests along with improved healthcare outcomes.

 

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports

  • Direct-to-Consumer Genetic Testing Market: Genetic test have traditionally been interpreted or ordered in a medical or clinical research setting. However, the last few years has witnessed a high growth in DTC genetic tests that offer consumers with the opportunity to learn about genetic profiles without participation of healthcare professionals. 
  • Rapid Tests Market: The global rapid tests market size was valued at USD 1.29 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.6% from 2023 to 2030.

 

Key Companies Profile

Some prominent players in the global hereditary testing market include:

  • Myriad Genetics, Inc.
  • Invitae Corporation
  • Illumina, Inc.
  • Natera, Inc.
  • Laboratory Corporation of America Holdings
  • Hoffmann-La Roche Ltd.
  • Quest Diagnostics Incorporated
  • CooperSurgical, Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Twist Bioscience
  • Sophia Genetics
  • Fulgent Genetics, Inc.
  • MedGenome
  • CENTOGENE N.V.

 

Order a free sample PDF of Hereditary Testing Market Intelligence Study, published by Grand View Research. 

Comments

Post a Comment

Popular posts from this blog

Global Potash Market: Trends, Growth & Forecast 2023-2032

T he global  potash market  size is expected to reach USD 93.50 billion by 2032, growing at a CAGR of 4.9% from 2023 to 2032, according to a new study by Grand View Research, Inc. This is attributed to the increasing demand for food and efficient usage of agricultural land. As consumers seek healthier options, there has been a surge in demand for high-value crops like fruits, vegetables, and specialty crops, boosting the demand for potash. Furthermore, the adoption of precision agriculture techniques has become increasingly prevalent in recent years. Precision agriculture involves using advanced technologies and data-driven approaches, such as soil testing and targeted nutrient management, to make informed decisions about fertilizer application.   Farmers are embracing precise and site-specific methods for applying fertilizers, based on field variability and crop requirements. This trend makes way for optimized resource utilization, improved crop performance, and enhanced...
Read more

Smart Ticketing Market Report: Emerging Technologies & Market Opportunities

  The global smart ticketing market size is expected to reach USD 31.65 billion by 2030, growing at a CAGR of 15.5% from 2023 to 2030, according to a new report by Grand View Research, Inc. With the widespread adoption of smartphones, mobile ticketing channels have gained traction, allowing users to purchase, store, and validate tickets directly on their mobile devices, eliminating the need for physical cards or paper tickets. The convenience and ease of use offered by mobile ticketing have contributed to the growth of the market. Smart ticketing systems generate vast amounts of data on passenger journeys, travel patterns, and ticket usage.   Operators leverage this data to gain valuable insights, optimize operations, and improve the overall passenger experience. Data analytics techniques, such as predictive modeling and real-time monitoring, are being applied to enhance efficiency, manage capacity, and offer personalized services, which bode well for smart ticketing...
Read more

Boosting Crop Yields: India Foliar Fertilizer Market Trends & Forecasts

  The  India foliar fertilizer market  size is expected to reach USD 4.9 billion by 2030, expanding at a CAGR of 11.3% during the forecast period, as per a new report by Grand View Research, Inc. The industry growth is majorly driven by surged demand for food due to increasing population coupled with supportive government initiatives and decreasing arable land in the country.   There has been a significant increase in the global prices of fertilizers and foliar fertilizers. As such, farmers falling into small- and marginal-income categories cannot afford to buy fertilizers resulting in reduced agricultural yields. This has led the Government of India to take initiatives to provide fertilizer subsidies to farmers in the country to make them affordable at subsidized prices. For instance, the Government of India announced a subsidy scheme related to fertilizers worth USD 27 billion in 2022 to ensure that fertilizers are affordable for every farmer in the country. Thus, ...
Read more